sever
acut
respiratori
syndrom
coronaviru
sarscov
caus
agent
sar
pandem
result
human
infect
worldwid
approxim
fatal
rate
ksiazek
et
al
peiri
et
al
viru
infect
upper
airway
alveolar
epitheli
cell
result
mild
sever
lung
injuri
human
sar
outbreak
investig
epidemiolog
evid
zoonot
origin
sarscov
identifi
xu
et
al
isol
sarsrel
coronaviru
sarsrcov
mask
palm
civet
detect
sarscov
infect
human
work
wet
market
civet
sold
suggest
mask
palm
civet
could
serv
sourc
human
infect
subsequ
work
identifi
genet
divers
sarsrcov
chines
horsesho
bat
rhinolophu
sinicu
counti
yunnan
provinc
china
provid
strong
evid
bat
natur
reservoir
sarscov
ge
et
al
li
et
al
yang
et
al
sinc
divers
sarsrel
coronavirus
sarsrcov
detect
report
bat
differ
region
global
hu
et
al
importantli
sarsrcov
use
sarscov
receptor
angiotensin
convert
enzym
isol
ge
et
al
result
indic
sarsrcov
may
high
potenti
infect
human
cell
without
necess
intermedi
host
howev
date
evid
direct
transmiss
sarsrcov
bat
peopl
report
studi
perform
serolog
surveil
peopl
live
close
proxim
cave
bat
carri
divers
sarsrcov
roost
octob
collect
serum
sampl
resid
four
villag
jin
counti
yunnan
provinc
china
fig
locat
km
two
cave
yanzi
shitou
conduct
longitudin
molecular
surveil
bat
cov
cave
sinc
found
inhabit
larg
number
bat
includ
rhinolophu
spp
major
reservoir
sarsrcov
region
involv
sar
outbreak
none
subject
exhibit
evid
respiratori
ill
sampl
among
sampl
femal
male
median
age
rang
occup
data
obtain
particip
farmer
student
kept
own
livestock
pet
major
histori
exposur
contact
livestock
wild
anim
importantli
particip
wit
bat
fli
close
hous
one
handl
bat
corps
control
also
collect
serum
sampl
random
blood
donor
electron
supplementari
materi
onlin
version
articl
http
contain
supplementari
materi
avail
author
user
wuhan
hubei
provinc
km
away
jin
fig
inhabit
much
lower
likelihood
contact
bat
due
urban
set
none
donor
knowledg
prior
sar
infect
known
contact
sar
patient
histag
nucleocapsid
protein
np
follow
virus
express
purifi
e
coli
studi
sarsrcov
human
coronavirus
hcov
middl
east
respiratori
syndrom
coronaviru
merscov
ebola
viru
ebov
addit
receptor
bind
domain
rbd
spike
protein
sarscov
bat
sarsrcov
produc
mammalian
cell
ge
et
al
yang
et
al
polyclon
antibodi
six
np
prepar
rabbit
previous
publish
et
al
crossact
evalu
elisa
western
blot
supplementari
figur
signific
crossact
detect
among
np
correspond
antibodi
merscov
crossreact
detect
report
previous
lehmann
et
al
np
chosen
develop
sarsrcov
specif
elisa
serosurveil
microtit
plate
coat
ngwell
recombin
np
incub
human
sera
duplic
dilut
follow
detect
hrp
label
goat
antihuman
igg
antibodi
proteintech
wuhan
china
dilut
random
serum
sampl
collect
wuhan
two
sar
posit
sampl
zhujiang
hospit
southern
medic
univers
kindli
provid
prof
xiaoyan
che
use
set
cutoff
valu
use
mean
od
valu
sampl
plu
three
standard
deviat
set
cutoff
valu
total
six
posit
sampl
detect
elisa
fig
specif
posit
sampl
confirm
western
blot
recombin
np
fig
togeth
np
merscov
ebov
degre
reactiv
western
blot
correl
well
elisa
od
read
provid
confid
elisa
screen
method
none
sera
react
np
either
merscov
ebov
hand
human
sera
jin
wuhan
regardless
np
reactiv
react
strongli
np
expect
due
high
preval
infect
human
worldwid
abdulrasool
field
conduct
viru
neutral
test
six
posit
sampl
target
two
sarsrcov
ge
et
al
yang
et
al
none
abl
neutral
either
viru
sera
also
fail
react
western
blot
recombin
rbd
protein
sarscov
three
bat
sarsrcov
also
perform
viral
nucleic
prof
xiaoyan
chedeceas
acid
detect
oral
fecal
swab
blood
cell
none
posit
demographi
travel
histori
six
posit
individu
four
male
two
femal
follow
two
male
year
old
year
old
dafengk
villag
two
male
year
old
year
old
lvxi
villag
two
femal
year
old
tianj
villag
month
prior
sampl
date
individu
travel
outsid
yunnan
shenzhen
citi
km
away
home
villag
fig
travel
anoth
counti
km
away
villag
travel
kunm
capit
yunnan
km
away
never
left
villag
worth
note
observ
bat
fli
villag
studi
provid
first
serolog
evid
like
human
infect
bat
sarsrcov
potenti
relat
virus
lack
prior
exposur
sar
patient
peopl
survey
lack
prior
travel
area
heavili
affect
sar
outbreak
rapid
declin
detect
antibodi
sarscov
recov
patient
within
year
infect
strongli
suggest
posit
serolog
obtain
studi
due
prior
infect
sarscov
wu
et
al
seroposit
high
risk
group
resid
live
close
proxim
bat
coloni
suggest
spillov
rel
rare
event
howev
depend
long
antibodi
persist
peopl
sinc
individu
may
expos
antibodi
wane
question
none
seroposit
subject
could
recal
clinic
symptom
past
month
suggest
bat
sarsrcov
infect
either
occur
time
sampl
infect
subclin
caus
mild
symptom
previou
work
base
cellular
human
mous
infect
studi
suggest
virus
less
virul
sarscov
ge
et
al
menacheri
et
al
yang
et
al
howev
consid
individu
high
chanc
direct
exposur
bat
secret
villag
studi
support
notion
bat
sarsrcov
abl
directli
infect
human
without
intermedi
host
suggest
receptor
entri
anim
infect
studi
menacheri
et
al
failur
np
elisa
posit
sera
either
neutral
live
viru
react
rbd
protein
western
blot
could
explain
least
two
hypothes
first
immun
respons
bat
sarsrcov
protein
may
weaker
np
protein
may
wane
rapidli
especi
subclin
infect
result
antibodi
level
low
detect
assay
secondli
bat
sarsrcov
variant
may
circul
bat
villag
highli
diverg
protein
yet
detect
surveil
studi
coronavirus
known
high
mutat
rate
replic
prone
recombin
differ
virus
infect
individu
knipe
et
al
previou
studi
bat
sarsrcov
two
cave
near
villag
found
genet
highli
divers
bat
sarsrcov
evid
frequent
coinfect
two
differ
sarsrcov
bat
ge
et
al
current
studi
suggest
surveil
exhaust
one
would
expect
extens
surveil
region
warrant
might
also
prudent
combin
serolog
surveil
molecular
surveil
bat
futur
despit
technolog
challeng
repres
